Comparing the current results to its competitors, Inspira Technologies Oxy B H N Ltd reported Revenue increase in the 4 quarter 2024 by 0 % year on year. The revenue growth was below Inspira Technologies Oxy B H N Ltd's competitors' average revenue growth of 10.15 %, achieved in the same quarter.
Inspira Technologies Oxy B H N Ltd's Comment on Competition and Industry Peers
The company utilizes trade secrets, know-how, and continuous innovation to sustain its competitive position. It actively manages its patent portfolio by filing new patent applications, prosecuting existing patents, and licensing or acquiring patents. However, there is uncertainty about the granting and commercial applicability of patents, and its intellectual property rights may be challenged or may not provide a sufficient competitive advantage.
November 13, 2025
In the rapidly evolving field of medical diagnostics, non-invasive technologies are becoming increasingly significant. They not only enhance patient comfort but also promise quicker and safer evaluation processes. Recently, Inspira Technologies OXY B.H.N. Ltd., announced a significant milestone in the development of its HYLA blood sensor, an innovative step forward in non-invasive diagnostic technology. This article explores the implications of this development, evaluates the clinical study s significance, and considers the future of such technologies in medical practice. Completion of Clinical Study On November 13, 2025, Inspira Technologies, a company known for its groundbreaking contributions to life-supp...
September 2, 2025
The landscape of respiratory care is evolving, particularly within the realm of organ transplantation, where innovative technologies are reshaping treatment paradigms. Inspira Technologies OXY B.H.N. Ltd. has made significant strides in this field with the expansion of its promising INSPIRA ART100 system. Recently, a top U.S. hospital, recognized in the U.S. News and World Report 2025-2026 Best Hospitals Honor Roll, has integrated this advanced life-support system into its lung transplantation procedures one of the most intricate and high-stakes interventions in modern medicine.The INSPIRA ART100 system underscores a paradigm shift in advanced respiratory support, particularly for patients requiring organ tr...
February 6, 2025
Inspira Technologies Enhances AI-Driven Blood Sensor, Aims for Clinical Advancements Amidst Competitive ChallengesIn recent developments, Inspira Technologies (NASDAQ: IINN) has positioned itself at the forefront of technological innovation in the healthcare sector with its latest advancements to the HYLA blood sensor technology. This update, as outlined in the recent PESG report, signifies a crucial step forward in addressing critical medical needs through artificial intelligence, particularly regarding the monitoring and management of oxygen levels in patients.The integration of a next-generation oxygenation indicator into the HYLA system is particularly noteworthy. This enhancement allows for the rapid d...
Publicly Traded Peers of Inspira Technologies Oxy B H N Ltd
Neuronetics Inc Share Performance
+74.36%
This Quarter
Neuronetics Inc
Profile
Neuronetics Inc is a medical device company focused on developing and commercializing non-invasive brain stimulation therapies for psychiatric disorders. Their business model primarily revolves around manufacturing and selling their flagship product, the NeuroStar Advanced Therapy System, which is used for the treatment of major depressive disorder. They generate revenue through the device sales, along with providing support services and maintenance to the healthcare facilities implementing their technology.
Sources:
Inspira Technologies Oxy B H N Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Inspira Technologies Oxy B H N Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
